Landscapes / Companies
VLP Therapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 1
Drugs
2
in active trials · 5 in all
Trials
2 active
3 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | 30 Dec 2027Phase 1 trial completes | |||
| Next date | 30 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Head and Neck Cancers- Squamous Cell, Head and Neck Cancer and 11 more | ||||
| Open drug page | |||||
— |
Phase 1 | 15 Mar 2028Phase 1 trial completes | |||
| Next date | 15 Mar 2028 · Phase 1 trial completes | ||||
| Also tested for | Randomised Clinical Trial, Double Blind and 3 more | ||||
| Open drug page | |||||
About
- No active trial
- 15 microgram VLPM01, 30 microgram VLPM01, 5 microgram VLPM01
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021